Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research Downgrades Edwards Lifesciences to Peer Perform

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

December 2, 2022

1 minute read

Wolfe Research analyst Mike Polark downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Peer Perform.

Coinbase CEO Mints Exclusive NFT To Fight Back Against US Regulatory Issues

April 25, 1:38 AM

Coinbase (NASDAQ:COIN) CEO Brian Armstrong, on Monday, minted a commemorative NFT in response to regulatory challenges facing the…

February 8, 2:00 PM

Ratings for Synchrony Finl (NYSE:SYF) were provided by 8 analysts in the past three months, showcasing a mix…

October 17, 7:53 AM

Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse

November 17, 10:24 AM

Goldman Sachs analyst Kate McShane maintains Target (NYSE:TGT) with a Buy and lowers the price target from $205 to $175.